Paper411364
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B and 5 others. Am J Cardiol, 1977. Cited by 168 papers, by iCite.
Cite this record
ConductScience Library. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Papers, record 411364. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/411364
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Hemodynamics | Major topic |
| Hydralazine | Major topic |
| Isosorbide Dinitrate | Major topic |
| Nitroglycerin | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Blood Pressure | |
| Cardiac Output | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Vascular Resistance | |
| Vasodilator Agents |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 168 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35257531 | Medical Management of Patients With Heart Failure and Reduced Ejection Fraction. | Korean Circ J | 2022 | https://conductscience.org/library/papers/35257531 | PubMed |
| 31120818 | Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction. | Circ Res | 2019 | https://conductscience.org/library/papers/31120818 | PubMed |
| 18748618 | General and family practice-epitomes of progress: nitrates in treatment of congestive heart failure. | West J Med | 1980 | https://conductscience.org/library/papers/18748618 | PubMed |
| 8097924 | Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. | Cardiovasc Drugs Ther | 1993 | https://conductscience.org/library/papers/8097924 | PubMed |
| 7253539 | Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/7253539 | PubMed |
| 7225252 | Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. | Br Heart J | 1981 | https://conductscience.org/library/papers/7225252 | PubMed |
| 6804202 | Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use. | Drugs | 1982 | https://conductscience.org/library/papers/6804202 | PubMed |
| 6753895 | Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6753895 | PubMed |
| 6349967 | Vasodilator therapy in chronic congestive heart failure. | Drugs | 1983 | https://conductscience.org/library/papers/6349967 | PubMed |
| 6224502 | A radionuclide method for the simultaneous study of the effects of drugs on central and peripheral haemodynamics. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6224502 | PubMed |
| 3743613 | The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3743613 | PubMed |
| 3304959 | Use of nitrates in acute and chronic congestive heart failure. | Drugs | 1987 | https://conductscience.org/library/papers/3304959 | PubMed |
| 3281740 | Congestive heart failure. | CMAJ | 1988 | https://conductscience.org/library/papers/3281740 | PubMed |
| 3024949 | The treatment of heart failure. A methodological review of the literature. | Drugs | 1986 | https://conductscience.org/library/papers/3024949 | PubMed |
| 2487535 | Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2487535 | PubMed |
| 360197 | Treatment of congestive cardiomyopathy. | Postgrad Med J | 1978 | https://conductscience.org/library/papers/360197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/411364
GET https://conductscience.org/api/papers/v1/411364/authors